Lisa Carey, MD, on Herceptin
UNC’s Lisa Carey, MD, discusses two major trials on the HER2-targeted therapy Herceptin
Herceptin Combinations Improve Survival, Lessen Heart Toxicity
ARTICLE ORIGINALLY PUBLISHED
IN WEB EXCLUSIVES
Please be patient, this video may take several seconds to a few minutes to begin playing,
depending on your download speed.
The latest version of Quicktime is recommended to view this video.
© 2012 CURE Media Group. All rights reserved. Terms of Use